{"id":"W2121366540","doi":"10.1176/ajp.2006.163.5.790","title":"Randomized, Double-Blind Trial of Olanzapine Versus Placebo in Patients Prodromally Symptomatic for Psychosis","year":2006,"lang":"en","type":"article","venue":"American Journal of Psychiatry","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":557,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Institute of Mental Health; University of Toronto; Eli Lilly and Company","keywords":"Olanzapine; Double blind; Placebo; Miller; Randomized controlled trial; Psychiatry; Psychology; Art; Medicine; Schizophrenia (object-oriented programming); Internal medicine","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01996867089890143,"score_gpt":0.3247760238200095,"score_spread":0.3048073529211081,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}